Pfizer Gears up for Earnings Amid Vaccine News

Pfizer will report earnings before the open on Tuesday, Nov. 2

Deputy Editor
Oct 28, 2021 at 1:57 PM
facebook twitter linkedin


Pfizer Inc (NYSE:PFE) has hogged the spotlight lately, especially after a key U.S. Food and Drug Administration (FDA) panel endorsed the company's low-dose Covid-19 vaccine for children ages 5 to 11. Plus, Pfizer is gearing up for its third-quarter earnings report, due out before the open on Tuesday, Nov. 2. 

Ahead of these earnings, the options pits are pricing in a post-earnings swing of 4.5%, regardless of direction, which is higher than the average 2.5% move from the company's last eight earnings reports. Pfizer has a split history of post-earnings reactions, closing four of the last eight next-day sessions with gains -- including the two most recent reports. 

On the charts, PFE has been on the rise since bouncing off the $41 level and 160-day moving average in mid October, after steadily dropping from its August 18 record high of $51.86. Though the 40-day moving average has kept a cap on gains this week, the equity just broke past several short- and long-term moving averages above the $42 level, including the 10-day trendline.

There is plenty of room for bull notes that could send Pfizer stock higher. Of the 11 analysts in coverage, seven still carry a tepid "hold" rating on the pharmaceutical name. 

Pfizer 1028

  

 

Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 

 


 


 
Special Offers from Schaeffer's Trading Partners